About Liposonix
Liposonix is a company based in Hayward (United States) founded in 1999 was acquired by Solta in September 2011. Liposonix has raised $37.94 million across 3 funding rounds from investors including The Carlyle Group, Solta and Pinnacle Ventures. The company has 6,139 employees. Liposonix operates in a competitive market with competitors including Zeltiq, CoolSculpting, Nitinote Surgical, Standard Bariatrics and HourGlass Technologies, among others.
- Headquarter Hayward, United States
- Employees 6,139
- SectorsHealthcare
- Email••••••••
- Website liposonix.com
- Social LinkedIn X
- Acquired by Solta (Sep 2011)
- Legal Name Bausch Health Companies Inc.
- Annual Revenue$9.52 B (USD)7832as on Dec 31, 2024
- Net Profit-$46 M (USD)-142as on Dec 31, 2024
- EBITDA$3.93 B (USD)154as on Dec 31, 2024
- Total Equity Funding$37.94M (USD)
in 3 rounds
- Latest Funding Round$27M (USD), Series C
Jul 2004
- InvestorsThe Carlyle Group
& 9 more
- Employee Count6,139
- Acquired by
Funding Insights of Liposonix
Liposonix has successfully raised a total of $37.94M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $27 million completed in July 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $37.94M
- Total Rounds 3
- Last Round Series C — $27M
- First Round $9.94M
(Oct 2002)
- Investors Count 8
All 3 funding rounds of Liposonix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2004 | $27M | Series C | – | Three Arch Partners | |
| Apr 2004 | $1M | Series B | – | – | – |
| Oct 2002 | $9.94M | Series B | – | – | – |
10 investors in total: 10 institutional.
Investors in Liposonix
Liposonix has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include The Carlyle Group, Solta and Pinnacle Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life science & tech focused VC firm investing in companies in the US | – | threearchpartners.com | San Mateo, United States | |
Investments are made in life sciences firms across all stages. | – | delphiventures.com | Menlo Park, United States | |
Early-stage US healthcare investments are made by Accuitive Medical Ventures. | – | amvpartners.com | Duluth, United States | |
Private equity investments are directed toward multiple sectors. | 1986 | carlyle.com | - | |
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | – | versantventures.com | - | |
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | – | ewhealthcare.com | New York, United States | |
Venture debt and equity financing are provided across US sectors. | 2002 | pinnacleventures.com | Palo Alto, United States | |
Venture capital fund focused on early-stage healthcare startups | – | svhealthinvestors.com | Boston, United States | |
Specialty pharmaceuticals for dermatological conditions are developed and marketed. | 1988 | medicis.com | Scottsdale, United States | |
Energy-based aesthetic medical devices are designed and marketed. | 1995 | solta.com | Hayward, United States |
Investor details for Liposonix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Liposonix
5 dated milestones of Liposonix across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Liposonix is founded.
- Funding First funding round of $9.9M.
- Funding Latest funding round, Series C, of $27.0M.
- Exit Acquired by Medicis Pharmaceutical.
- Exit Acquired by Solta.
Competitors of Liposonix
Liposonix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zeltiq, CoolSculpting, Nitinote Surgical, Standard Bariatrics and HourGlass Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zeltiq.com | 2005 | Pleasanton, United States | $70.42M | – | Controlled cooling technology is developed for non-surgical fat reduction. | |
| coolsculpting.com | 2005 | Pleasanton, United States | – | 82 | Non-surgical fat reduction is achieved through controlled-cooling technology. | |
| nitinotesurgical.com | 2014 | Ramat Gan, Israel | $26.1M | – | Non-surgical bariatric solutions for obesity are developed. | |
| standardbariatrics.com | 2014 | Cincinnati, United States | $35.5M | 34 | Medical devices for obesity surgical treatment are provided. | |
| hourglasstech.com | 2007 | Redwood, United States | – | – | Weight-loss solutions are developed via incision-free transoral procedures. | |
| modiushealth.com | 2017 | Belfast, United Kingdom | $1.59M | 21 | Non-invasive vestibular stimulation device for weight loss is offered. | |
| ultrashape.com | 2002 | Irvine, United States | $15M | – | Non-invasive fat cell destruction for body contouring | |
| cabochoninc.com | 2005 | Menlo Park, United States | $14.79M | – | Delivers an ultrasound system for disrupting subcutaneous tissue in medical applications. | |
| stemcis.com | 2008 | Illkirch-graffenstaden, France | – | – | Provider of fat transfer kits for various medical specialties |
Detailed competitors of Liposonix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Liposonix
Websites that share an audience with Liposonix (liposonix.com).
Websites whose visitors overlap most with Liposonix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| solta.com | 100% | 9.1K | #2,668,515 | View details | |
| medicointernational.com | 91% | 3.2K | #5,264,925 | View details | |
optopol.com.pl | optopol.com.pl | 87% | – | #5,359,608 | – |
divaclinic.com | divaclinic.com | 87% | – | #2,296,168 | – |
beautymed.kz | beautymed.kz | 87% | – | #7,889,751 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Liposonix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Liposonix
Complete news archive for Liposonix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Liposonix
10 companies that operate in the same segment as Liposonix (Metabolic Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies | 2010 | Boston, Massachusetts, United States | USD 84 M | USD 189.76 M | 283 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Developer of cortisol modulators for the treatment of various diseases | 1998 | Menlo Park, California, United States | – | USD 761.41 M | 500 | |
Developer of therapies for the treatment of endocrine-related diseases and cancers | 2008 | San Diego, California, United States | USD 103.5 M | USD 1.04 M | 437 | |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed. | 2009 | Cambridge, Massachusetts, United States | USD 685 M | – | 81 | |
Developer of small molecule therapeutics for endocrine and CNS disorders | 1992 | San Diego, California, United States | USD 10 M | USD 2.86 B | 1,800 | |
Solutions for biomarker discovery and diagnostic testing are provided. | 2000 | Morrisville, United States | USD 165.87 M | – | – | |
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed. | 2007 | Fremont, California, United States | USD 61.1 M | USD 407.32 M | 395 | |
Biologics are developed for cardio-metabolic and liver diseases. | 2007 | San Francisco, California, United States | USD 358.87 M | USD 330.53 M | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Liposonix
Liposonix was founded in 1999 and raised its 1st funding round 3 years after it was founded.
Liposonix is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Liposonix is a funded company, having raised a total of $37.94M across 3 funding rounds to date. The company's 1st funding round was a Series B of $9.94M, raised on Oct 2002.
Liposonix has 6,139 employees.
Annual revenue of Liposonix is $9.52B as on Dec 31, 2024.
Liposonix was founded in 1999 in Hayward, United States, within the medical aesthetics sector. Non-surgical systems are developed by the company to reduce fat in the waist and abdomen using high-frequency ultrasound waves applied externally. The Liposonix System is utilized for targeting fat tissue without invasion. Acquisition by Medicis Technologies Corporation occurred in 2008 for 300 million, with Medicis operating as a subsidiary of Solta Medical, Inc.
Liposonix's top competitors include Nitinote Surgical, CoolSculpting and Standard Bariatrics.
Liposonix has 10 investors. Key investors include The Carlyle Group, Solta, Pinnacle Ventures, Medicis Pharmaceutical, and Three Arch Partners.
Liposonix operates through Bausch Health Companies Inc..
Yes. Liposonix was acquired by Solta in September 2011.